A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Clinical trial NCT04973657 · COMPLETED

Trial details

NCT number: NCT04973657
Sponsor: Viking Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Start date: 2021-06-22
Primary completion: 2024-10-09
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.